The chemical structure of tranexamic acid is similar to lysine, competitive inhibition of plasmin original in fibrin adsorption, to prevent their activation, protection fiber protein not to degrade by plasmin and dissolve, eventually achieve hemostasis. Applicable in the treatment of acute or chronic, localized or systemic primary fiber fibrinolytic hyperthyroidism caused by bleeding, such as obstetric hemorrhage, renal hemorrhage, hemorrhage of hypertrophy of the prostate, hemophilia, pulmonary tuberculosis hemoptysis, stomach bleeding, after operation of liver, lung, spleen and other viscera hemorrhage; also can be used in surgery when abnormal bleeding etc..
Clinical tranexamic acid has effect significantly to insect bites disease, dermatitis and eczema, simple purpura, chronic urticaria, artificial sex urticaria, toxic eruption and eruption. And also has a certain effect on erythroderma, scleroderma, systemic lupus erythematosus (SLE), Erythema multiforme, shingles and alopecia areata. Treatment of hereditary angioedema effect is also good. In the treatment of Chloasma, general medicine is effective about 3 weeks, markedly effective 5 weeks, a course of 60 days. Given orally in doses of 0.25 ~ 0.5 g, a day 3 ~ 4 times. A few patients can nausea, fatigue, pruritus, abdominal discomfort, and diarrhea side effects after withdrawal symptoms disappear.
1.Tranexamic acid is mainly used for various types of bleeding caused by acute or chronic, localized or systemic fibrinolysis.
2. The melamine-removing effect of tranexamic acid is about 50 times higher than vitamin C and nearly 10 times that of fruit acid, so it can also be used for skin whitening.
3. Pay attention to the secondary high fibrinolysis state caused by disseminated intravascular coagulation, and use this product with caution before heparinization.
Anyị nwere ọtụtụ ụlọ ọrụ dị elu nke nwere nkwado miri emi, nke nwere ike inye gị ngwaahịa dị elu na ọnụ ahịa asọmpi. Anyị nwekwara ike inye ego maka nnukwu ịzụrụ ihe. Anyị na-akwado ọtụtụ ụlọ ọrụ na-ebuga ibu ndị ọkachamara, nwere ike ịnapụta ngwaahịa n'enweghị nsogbu na aka gị. Oge nnyefe bụ ihe dịka ụbọchị 3-20 mgbe nkwenye nke ịkwụ ụgwọ gasịrị.
Ihe | Nkọwapụta | Test Results |
Ọdịdị | White powder, neutral odor, highly hygroscopic | Kwado |
njirimara | TLC:Standard solution and test solution same spot,RF | Kwado |
Assay (Dry Basis) | 98.0%--102.0% | 100.98% |
Specific Optical | -2.4°~ -2.8° | -2.71° |
PH | 4.5~7.0 | 5.3 |
Heavy Metals (As Pb) | ≤10ppm | <10ppm |
Dị ka | ≤1ppm | Not Detected |
Pb | ≤0.5ppm | Not Detected |
Cd | ≤1ppm | Not Detected |
Hg | ≤0.1ppm | Not Detected |
Related substance | Spot not bigger than standard solution spot |
No spot |
Residual solvent | <0.5% | Na-akwado |
Water Content | <2% | 0.18% |
Tranexamic acid is a White or almost white, crystalline powder. It is freely soluble in water and in glacial acetic acid and is very slightly soluble in ethanol and practically insoluble in ether. Tranexamic acid is an antifibrinolytic agent and is commonly used for heavy menstrual bleeding. Tranexamic acid is a monocarboxylic acid. It has a role as an antifibrinolytic drug and a hematologic agent. It is functionally related to a cyclohexanecarboxylic acid.
Uses
Fibrinolysis, the cleavage of fibrin by plasmin, is a normal step in the dissolution of fibrin clots after wound repair. Tranexamic acid is an inhibitor of fibrinolysis that blocks the interaction of plasmin with fibrin (IC50 = 3.1 μM). It is a lysine mimetic that binds the lysine binding site in plasmin. Antifibrinolytic agents have value when fibrinolytic activity is abnormally high or when coagulation is impaired.
Various bleedings caused by acute or chronic, localized or systemic primary hyperfibrinolysis; secondary hyperfibrinolytic state caused by disseminated intravascular coagulation. Generally do not use this product before heparinization.
Trauma or surgical bleeding in tissue and organs with abundant plasminogen activators such as prostate, urethra, lung, brain, uterus, adrenal glands, and thyroid.
1. Ị bụ ụlọ ọrụ mmepụta ihe ma ọ bụ ụlọ ọrụ ịzụ ahịa?
Anyị bụ ụlọ ọrụ na-ejikọta ụlọ ọrụ na ịzụ ahịa, na-enye ọrụ nkwụsịtụ.OEM nwere ike ịnakwere.
2. Ị na-enye samples? Ọ bụ n'efu ka ọ bụ mgbakwunye?
Free samples. The sample si ibu ego kwesịrị ịkwụ ụgwọ gị n'akụkụ.
3. Ị nwere asambodo ọ bụla metụtara njikwa mma?
ISO 9001: 2008 asambodo iji hụ na ịdị mma.
4. Kedu ihe m ga-enye ka m nweta nhota okwu?
Pls na-agwa anyị ụdị ngwaahịa nke ị chọrọ, iji ọnụ ọgụgụ, adreesị na ihe ndị a chọrọ. A ga-edepụta nkwupụta maka ntinye aka gị n'oge.
5. Kedu ụdị usoro ịkwụ ụgwọ na-amasị gị? Kedu ụdị usoro anabatara?
Usoro nnyefe anabatara: FOB, CFR, CIF, EXW;
Ego ịkwụ ụgwọ anabatara: USD;
Ụdị ịkwụ ụgwọ anabatara: T/T, Western Union; Paypal, ahia ahia.
Asụsụ Asụsụ: Bekee.
Ụdị ngwaahịa